Toray Of Japan, University Develop Insulin Nasal Spray For Diabetes
This article was originally published in PharmAsia News
Japan's Toray Industries and a university disclosed they have developed an insulin for diabetics that can be administered through a nasal spray. Toray and Hoshi University said their method combines a peptide with insulin to form a liquid that can be delivered in spray form. The method, if proven successful, would substitute for diabetic reliance on regular insulin injections. Testing of the method in mice, according to researchers, showed that 50 percent of the insulin administered in that manner enters the blood to help lower blood sugar levels. The team plans to begin clinical trials to prove the method is efficacious and safe in humans. (Click here for more - a subscription may be required
You may also be interested in...
In final rule describing the types of evidence the agency will consider in determining the ‘intended use’ of a product, FDA rejects industry requests to exclude ‘circumstances surrounding distribution’ and product design or composition.
User fees for FY 2021 were set to increase nearly 11%, but could have gone even higher; a new notice will be issued but timing is unclear.
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.